Endo International

Jump to

New launches to drive earnings growth in FY18 & FY19: Glenmark

The company has a strong pipeline of products which the company, CMD Glenn Saldanha said adding that new launches will drive earnings for the company in FY18 and FY19. The company has no plans to raise further capital, he said.
Endo to buy Par Pharmaceuticals from TPG Cap for $8.05 bn

The company, which filed with US regulators in March for an initial public offering of common stock, had debt of USD 2.35 billion as of March 31.
Dr Reddy's, Endo get FDA approval to launch generic Valcyte

The US Food and Drug Administration (FDA) said it has granted final approval to Indian drugmaker Dr Reddy's Laboratories and US firm Endo International Plc to make cheaper copies of Roche Holding AG's antiviral Valcyte.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Endo International

New launches to drive earnings growth in FY18 & FY19: Glenmark

Endo to buy Par Pharmaceuticals from TPG Cap for &#36;8.05 bn

Dr Reddy's, Endo get FDA approval to launch generic Valcyte

Endo to buy Par Pharmaceuticals from TPG Cap for $8.05 bn